*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : RH6315000
CHEMICAL NAME : D-erythro-D-galacto-Octopyranoside, methyl
6,8-dideoxy-6-(1-methyl-4-propyl-L-2-
pyrrolidinecarboxamido)-1-thio-, monohydrochloride,
trans-alpha-
CAS REGISTRY NUMBER : 859-18-7
OTHER CAS REGISTRY NOS. : 59112-35-5
LAST UPDATED : 199612
DATA ITEMS CITED : 15
MOLECULAR FORMULA : C18-H34-N2-O6-S.Cl-H
MOLECULAR WEIGHT : 443.06
WISWESSER LINE NOTATION : T6OTJ BS1 CQ DQ EQ FYYQ1&MV- BT5NTJ A1 D3
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Lincocin
* Lincomycin hydrochloride
* U 10149a
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1260,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 9778 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
9,445,1966
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 342 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
6,476,1964
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1260,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 750 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BFPHA8 Bulletin of the Faculty of Pharmacy (Cairo University). (Faculty of
Pharmacy, Cairo Univ., Cairo, Egypt) V.1- 1961/62-
Volume(issue)/page/year: 18,131,1979
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1260,1990
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 214 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
6,476,1964
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: -,1260,1990
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
6,476,1964
TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : >300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
6,476,1964
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - guinea pig
DOSE/DURATION : 732 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BFPHA8 Bulletin of the Faculty of Pharmacy (Cairo University). (Faculty of
Pharmacy, Cairo Univ., Cairo, Egypt) V.1- 1961/62-
Volume(issue)/page/year: 18,131,1979
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 109200 mg/kg/52W-C
TOXIC EFFECTS :
Kidney, Ureter, Bladder - other changes
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E.
First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year:
6,476,1964
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - guinea pig
DOSE/DURATION : 300 mg/kg/3D-I
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea
Biochemical - Metabolism (Intermediary) - histamines (including liberation
not immunochemical in origin)
Related to Chronic Data - death
REFERENCE :
BFPHA8 Bulletin of the Faculty of Pharmacy (Cairo University). (Faculty of
Pharmacy, Cairo Univ., Cairo, Egypt) V.1- 1961/62-
Volume(issue)/page/year: 18,131,1979
*** OCCUPATIONAL EXPOSURE LIMITS ***
OEL-RUSSIA:STEL 0.5 mg/m3 JAN 1993
*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***
NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X4977
No. of Facilities: 808 (estimated)
No. of Industries: 3
No. of Occupations: 14
No. of Employees: 20887 (estimated)
No. of Female Employees: 10760 (estimated)
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
7-Octen-1-ol, 3,7-dimethyl-
| 141-25-3 |
7-Octen-1-ol, 3,7-dimethyl-, (S)-
| 6812-78-8 |
7-Octen-2-ol, 2,6-dimethyl-
| 18479-58-8 |
6-Octen-1-ol, 3,7-dimethyl-, acetate
| 150-84-5 |
6-Octen-4-ol, 2,7-dimethyl-, acetate
| 102-58-9 |
7-Octen-1-ol, 3,7-dimethyl-, acetate
| 141-11-7 |
6-Octen-1-ol, 3,7-dimethyl-, butyrate
| 141-16-2 |
6-Octen-1-ol, 3,7-dimethyl-, crotonate
| 68039-38-3 |
Nortoxiferinium, N,N'-diallyl-, dichloride
| 15180-03-7 |
6-Octen-1-ol, 3,7-dimethyl-, formate
| 105-85-1 |
7-Octen-2-ol, 2,6-dimethyl-8-(1H-indol-1-yl)-
| 68527-79-7 |
7-Octen-1-ol, 3,7-dimethyl-, propionate
| 105-89-5 |
1-Octen-3-ol, 3-methyl-
| 24089-00-7 |
7-Octen-2-ol, 2-methyl-6-methylene-
| 543-39-5 |
7-Octen-2-ol, 2-methyl-6-methylene-, acetate
| 1118-39-4 |
1-Octen-2-one,4-((dimethylamino)methyl)-4-methyl-1-phenyl-,hydrochloride
| 1118-39-4 |
6-Octen-1-yn-3-ol, 3,7-dimethyl-, acetate
| 29171-21-9 |
6-Octen-4-yn-2-ol, 1-(dimethylamino)-6-ethyl-,hydrochloride
| 25708-11-6 |
d-Octopine, nitrosated
| 104639-48-7 |
1-alpha-H,5-alpha-H-Nortropane,8-benzyl-3-alpha-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten- 5-yl)oxy)-, maleate (1:1)
| 1630-89-3 |
D-erythro-D-galacto-Octopyranoside,2-hydroxyethyl-6,8-dideoxy-7-O-methyl-6-(1-methyl-L-2-pyrrolidinecarboxamido)-1-thio-, monosalicylate(ester), alpha-
| 2520-21-0 |
L-threo-D-galacto-Octopyranoside, methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha-
| 18323-44-9 |
D-erythro-D-galacto-Octopyranoside, methyl7-(S)-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, hydrochloride,trans-alpha-
| 17431-55-9 |
L-threo-alpha-D-galacto-Octapyranoside, methyl7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)ami no)-1-thio-, 2-(dihydrogenphosphate), (2S-trans)-
| 24729-96-2 |
L-threo-alpha-D-galacto-Octopyranoside, methyl7-chloro-6,7,8-trideoxy-6-(((4-pentyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-,monohydrochloride, (2S-cis)-
| 33054-87-4 |
D-erythro-alpha-D-galacto-Octopyranoside, methyl6,8-dideoxy-7-O-methyl-6-(((1-methyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (S)-
| 75007-09-9 |
D-erythro-D-Galacto-octopyranoside,methyl-6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha-
| 154-21-2 |
D-erythro-D-galacto-Octopyranoside, methyl6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride,trans-alpha-
| 859-18-7 |
D-erythro-D-Galacto-octopyranoside, methyl6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride,hemihydrate
| 7179-49-9 |
Octyl alcohol
| 111-87-5 |
1-alpha-H,5-alpha-H-Nortropane-2-beta-carboxylicacid, 3-beta-hydroxy-, methyl ester, benzoate (ester)
| 18717-72-1 |
Octyl alcohol, mixed isomers
| 29063-28-3 |
sec-Octyl alcohol
| 25339-16-6 |
Octylamine, acetate
| 2016-40-2 |
Octylamine, N-(2-(diethylamino)ethyl)-N-(2-pyridyl)-,trioxalate
| 101858-34-8 |
Octylamine,N-(3-(dimethylamino)propyl)-N-(2-pyridyl)-
| 25295-39-0 |
Octylamine, N,N-dimethyl-, hydrochloride
| 2016-50-4 |
1-Octylamine,N,N-dimethyl-5-imino-4-isopropyl-4-naphthyl-
| 13362-85-1 |
Octylamine, 4-ethyl-1-methyl-
| 10024-78-9 |
Octylamine, 8-fluoro-
| 593-16-8 |
Octylamine, N-methyl-N-nitroso-
| 34423-54-6 |
1-alpha-H,5-alpha-H-Nortropane, 3-alpha-chloro-,hydrochloride
| 14379-07-8 |
Octylamine,N-(2,3,6,7-tetrahydro-1H,5H-benzo(ij)quinolizin-9-yl)-, dihydrochloride
| 101858-35-9 |
Octyl ether
| 629-82-3 |
Octyl phenol condensed with 1 mole ethylene oxide
| 629-82-3 |
Octyl phenol condensed with 3 moles ethylene oxide
| 629-82-3 |
Octyl phenol condensed with 16 moles ethylene oxide
| 9036-19-5 |
Octyl phenol condensed with 20 moles ehtylene oxide
| 9036-19-5 |
2-Octynamide
| 9036-19-5 |
5-Octyn-4-amine, 4-ethyl-, hydrochloride
| 64467-43-2 |
|
|